SCHEMBL4548605

SCHEMBL4548605

C=Cc1cccc(COc2ccc(F)c3c(=O)c4ccccc4sc23)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.34
NPC1 O15118 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 1/20 0.34
MAOA P21397 6/20 0.34
MAOB P27338 6/20 0.34
POLB P06746 2/20 0.34
MRGPRX4 Q96LA9 2/20 0.33
F9 P00740 1/20 0.33
F10 P00742 1/20 0.33
PPOX P50336 1/20 0.33
SENP5 Q96HI0 1/20 0.33
SENP2 Q9HC62 1/20 0.33
SENP1 Q9P0U3 1/20 0.33
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2763154 0.85 NPC1 (0.40) MAPTNPC1CYP1A2CYP3A4CYP2C9
SCHEMBL10058703 0.75 MAPT (0.41) MAPTNPC1CYP1A2CYP3A4CYP2C9
SCHEMBL2125461 0.75 CYP1A2 (0.43) MAPTNPC1CYP1A2CYP3A4CYP2C9
SCHEMBL1614172 0.74 MAPT (0.43) MAPTNPC1CYP1A2CYP3A4CYP2C9
SCHEMBL13113515 0.73 MAPT (0.42) MAPTNPC1CYP1A2CYP3A4CYP2C9
SCHEMBL2127382 0.73 PTPN1 (0.49) MAPTNPC1CYP1A2CYP3A4CYP2C9
SCHEMBL25556876 0.72 MAPT (0.58) MAPTNPC1CYP1A2CYP3A4CYP2C9
SCHEMBL1615137 0.72 GPR84 (0.41) MAPTNPC1CYP1A2CYP3A4CYP2C9
SCHEMBL2606272 0.71 KDM4E (0.34) MAPTNPC1CYP1A2CYP3A4CYP2C9
SCHEMBL16785829 0.71 F9 (0.46) MAPTNPC1CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2444429-B1 LED CURABLE COMPOSITIONS AGFA GRAPHICS NV (BE) 2016-09-07 EP disclosed
EP-2447259-B1 Polymerisable photoinitiators for LED curable compositions AGFA GRAPHICS NV (BE) 2016-03-16 EP disclosed
US-8985753-B2 LED curable compositions AGFA GRAPHICS NV (BE) 2015-03-24 US disclosed
US-8985753-B2 LED curable compositions AGFA GRAPHICS NV (BE) 2015-03-24 US disclosed
US-8759412-B2 Polymerisable photoinitiators for LED curable compositions AGFA GRAPHICS NV (BE) 2014-06-24 US disclosed
US-8759412-B2 Polymerisable photoinitiators for LED curable compositions AGFA GRAPHICS NV (BE) 2014-06-24 US disclosed
US-20130210954-A1 POLYMERISABLE PHOTOINITIATORS FOR LED CURABLE COMPOSITIONS AGFA-GEVAERT N.V. (BE) 2013-08-15 US disclosed
US-20130210954-A1 POLYMERISABLE PHOTOINITIATORS FOR LED CURABLE COMPOSITIONS AGFA-GEVAERT N.V. (BE) 2013-08-15 US disclosed
US-20130176370-A1 LED CURABLE COMPOSITIONS AGFA-GEVAERT N.V. (BE) 2013-07-11 US disclosed
US-20130176370-A1 LED CURABLE COMPOSITIONS AGFA-GEVAERT N.V. (BE) 2013-07-11 US disclosed
EP-2447259-A1 Polymerisable photoinitiators for LED curable compositions Agfa-Gevaert (BE) 2012-05-02 EP disclosed
WO-2012052291-A1 LED CURABLE COMPOSITIONS AGFA-GEVAERT (BE) 2012-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210954-A1 POLYMERISABLE PHOTOINITIATORS FOR LED CURABLE COMPOSITIONS ADSL, ALAD, ACSL3 MAPT 1076/4885NPC1 4473/4885CYP1A2 848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.